Around 88% of patients with COVID-19 who were put on a ventilator in a New York hospital system died, according to a new study.
In the new study, researchers analyzed data from 5,700 patients who were hospitalized from March 1 to April 4 through Northwell Health, the largest health system in New York, with 12 hospitals across New York City, Long Island and Westchester County. Of those patients, 2,634 were discharged or had died by the end of the study, and 320 patients with a recorded outcome were put on ventilators. Nearly 9 in 10 of those ventilated patients died.
But age made a difference. Around 76% of ventilated patients between the ages of 18 and 65 died, and 97%, of ventilated patients over the age of 65 died, according to the report.
Of the 2,634 patients, ventilated or not, about 21% died, according to the researchers. But that meant the majority, or 3,066, of the patients were still hospitalized when the study ended, which could have "biased the findings," the authors wrote.
The researchers found that among the patients that were hospitalized, the most common underlying conditions were hypertension (around 56.6%), obesity (around 41.7%) and diabetes (around 33.8%).
The bleak statistics don't imply that the ventilators caused harm, said senior author Karina Davidson, senior vice president and professor at the Feinstein Institutes for Medical Research at Northwell Health.
Rather, "patients who are put on ventilators typically have more severe disease," and are therefore likelier to die, Davidson told Live Science in an email. "Mechanical ventilators are not dangerous, and in many cases, are life saving machines."
The findings were published April 22 in the journal JAMA.
- Going viral: 6 new findings about viruses
- The 12 deadliest viruses on Earth
- Top 10 mysterious diseases
Originally published on Live Science.
For a limited time, you can take out a digital subscription to any of our best-selling science magazines for just $2.38 per month, or 45% off the standard price for the first three months.
Sign up for the Live Science daily newsletter now
Get the world’s most fascinating discoveries delivered straight to your inbox.
Yasemin is a staff writer at Live Science, covering health, neuroscience and biology. Her work has appeared in Scientific American, Science and the San Jose Mercury News. She has a bachelor's degree in biomedical engineering from the University of Connecticut and a graduate certificate in science communication from the University of California, Santa Cruz.
I suggest an experiment: we already have an epidemiological track recording outcomes of those intubated with COVID-19 who received standard sedation with, benzodiazapines, most likely The question is simple: would intubation using barbiturate such as seconal for the sedative give a lower death rate? Higher? The same? Likewise, where a steroid is used, would the result be different with dexamethasone as opposed to salmedrol? These are valid questions and I pose no answer as such: I merely plause valid questions and propose experiments.Reply